January 2011

Sahajanand Medical Technologies is a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolio in the industry. We committed to the welfare of all patients around the world; we shall provide best evidence based products to fight cardiovascular disease. Sahajanand Medical Technologies has a strong international presence and we are proud to be a first company to secure CE mark for biodegradable polymer based Drug Eluting Stents.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

In Gujarat, state AIDS cell (SAC) was created in December 1992 for implementation of phase I of National AIDS Control Programme (NACP). The programme was implemented in accordance with the guidelines of NACP and the approved of the State Empowered Committee on AIDS as constituted in Gujarat.

Mangalam Drugs & Organics Ltd. - Commenced its business in 1977 of manufacturing of chemicals such as perfumery, organic/inorganic chemicals, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State.